NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,330 | +17.9% | 421 | -37.4% | 0.00% | 0.0% |
| Q4 2022 | $6,219 | +107.3% | 673 | +71.2% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 393 | +214.4% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | -77.8% | 125 | -66.9% | 0.00% | -66.7% |
| Q3 2021 | $18,000 | +80.0% | 378 | +79.1% | 0.00% | +50.0% |
| Q2 2021 | $10,000 | -23.1% | 211 | -23.0% | 0.00% | -66.7% |
| Q1 2021 | $13,000 | +62.5% | 274 | +80.3% | 0.01% | +50.0% |
| Q4 2020 | $8,000 | +33.3% | 152 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $6,000 | +20.0% | 152 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +25.0% | 152 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | +100.0% | 152 | +117.1% | 0.00% | +100.0% |
| Q4 2019 | $2,000 | 0.0% | 70 | -39.1% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | 0.0% | 115 | +64.3% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | +100.0% | 70 | +32.1% | 0.00% | – |
| Q1 2019 | $1,000 | – | 53 | -10.2% | 0.00% | – |
| Q3 2016 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 59 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
| Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
| First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
| PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
| Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
| EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
| Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
| OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
| FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |